• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

球部保留手术治疗前眶侵犯的内眦基底细胞癌。

Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.

机构信息

Discipline of Ophthalmology and Visual Sciences, University of Adelaide, South Australia.

出版信息

Ophthalmology. 2010 Nov;117(11):2222-8. doi: 10.1016/j.ophtha.2010.02.013. Epub 2010 Jun 8.

DOI:10.1016/j.ophtha.2010.02.013
PMID:20570356
Abstract

PURPOSE

To describe a case series of patients with anterior orbital invasion by medial canthal basal cell carcinoma (BCC) managed with non-exenterating surgery.

DESIGN

International, multicenter, retrospective, noncomparative, consecutive case series.

PARTICIPANTS

Twenty patients identified from the individual institutions' databases with histologically confirmed orbital invasion by periocular BCC.

METHODS

Examination of charts, relevant imaging, and histopathologic data.

MAIN OUTCOME MEASURES

Demographics; clinical characteristics and radiologic features; histopathologic features; surgical techniques for excision, reconstruction, and subsequent procedures; complications; visual acuity; and recurrence.

RESULTS

Twenty patients were identified. Twelve of 20 patients (60%) had recurrent BCCs, with 1 patient having had prior radiotherapy for previously incomplete excision. Eighteen of 20 patients (90%) had a palpable mass, 16 of 20 patients (80%) had clinical involvement of the nasolacrimal system, and 1 of 20 patients (5%) had limited extraocular movements. Preoperative radiologic evidence of orbital invasion was found in 10 of 20 patients (50%). Histologic evidence of orbital invasion was present in every patient, the subtypes being infiltrative (9/20, 45%), nodular (4/20, 20%), micronodular (2/20, 10%), multifocal (1/20, 5%), and mixed (4/20, 20%); extratumoral perineural invasion was present in 1 patient (5%). Final margins were clear in 18 of 20 patients (90%), positive in 1 of 20 patients (5%), and unclear in 1 of 20 patients (5%). Reconstruction was by direct closure in 1 patient and by a variety of standard oculoplastic flaps and grafts in 19 of 20 patients (95%). Twelve of 20 patients (60%) had postoperative extraocular muscle movement restriction, and 15 of 20 patients (75%) had epiphora. Subsequent revision procedures were needed in 12 of 20 patients (60%), including insertion of a lacrimal bypass tube and revision of medial canthal position. At a mean follow-up of 38 months, 18 of 20 patients (90%) were still alive (2 deaths due to other causes) with 1 recurrence (exenterated). Postoperative visual acuity was within 2 Snellen lines of preoperative visual acuity in 17 of 20 patients (85%).

CONCLUSIONS

With careful planning and margin control, conservative surgery in this highly selected group proved possible with a low rate of disease recurrence, albeit with a relatively short follow-up. Postoperative complications, such as epiphora and ophthalmoplegia, were largely expected; most patients underwent subsequent revision procedures to address these and other complications.

FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

摘要

目的

描述一组内侧眼角基底细胞癌(BCC)侵犯前眶患者的病例系列,这些患者采用非眼眶内容剜除术进行治疗。

设计

国际、多中心、回顾性、非对照、连续病例系列。

参与者

从各个机构的数据库中确定了 20 名经组织学证实为眼周 BCC 侵犯眼眶的患者。

方法

检查图表、相关影像学和组织病理学数据。

主要观察指标

人口统计学资料;临床特征和影像学特征;组织病理学特征;切除、重建和后续手术的外科技术;并发症;视力;和复发。

结果

共确定了 20 名患者。20 名患者中有 12 名(60%)为复发性 BCC,其中 1 名患者曾因先前不完全切除而行过放射治疗。20 名患者中有 18 名(90%)有可触及的肿块,16 名(80%)有鼻泪管系统的临床受累,1 名(5%)有有限的眼球运动。20 名患者中有 10 名(50%)术前影像学证据显示眼眶侵犯。20 名患者中均有组织学证据显示眼眶侵犯,亚型为浸润性(9/20,45%)、结节性(4/20,20%)、微结节性(2/20,10%)、多灶性(1/20,5%)和混合性(4/20,20%);1 名患者(5%)存在肿瘤外神经周围侵犯。20 名患者中有 18 名(90%)最终切缘为阴性,1 名(5%)阳性,1 名(5%)未明确。1 名患者采用直接闭合重建,19 名(95%)患者采用各种标准眼整形皮瓣和移植物重建。20 名患者中有 12 名(60%)术后出现眼外肌运动受限,15 名(75%)出现溢泪。20 名患者中有 12 名(60%)需要进行后续的修正手术,包括植入泪道旁路管和修正内眦位置。在平均 38 个月的随访中,20 名患者中有 18 名(90%)仍然存活(2 例因其他原因死亡),1 例复发(行眼眶内容剜除术)。术后视力在 20 名患者中有 17 名(85%)与术前视力相差 2 个 Snellen 线以内。

结论

在这一高度选择的患者群体中,通过仔细的规划和切缘控制,保守手术是可行的,疾病复发率较低,但随访时间相对较短。术后并发症,如溢泪和眼肌麻痹,是可以预期的;大多数患者需要进行后续的修正手术来解决这些并发症和其他并发症。

利益冲突声明

作者在本文讨论的任何材料中均没有专有的或商业的利益。

相似文献

1
Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.球部保留手术治疗前眶侵犯的内眦基底细胞癌。
Ophthalmology. 2010 Nov;117(11):2222-8. doi: 10.1016/j.ophtha.2010.02.013. Epub 2010 Jun 8.
2
Orbital invasion by periocular basal cell carcinoma.眼周基底细胞癌的眼眶侵犯
Ophthalmology. 2005 Apr;112(4):717-23. doi: 10.1016/j.ophtha.2004.11.036.
3
Risk factors for orbital exenteration in periocular Basal cell carcinoma.眼周基底细胞癌行眶内容剜除术的风险因素。
Am J Ophthalmol. 2012 Feb;153(2):238-241.e1. doi: 10.1016/j.ajo.2011.08.004. Epub 2011 Oct 6.
4
Destruction of the orbit and globe by recurrence of basal cell carcinoma.基底细胞癌复发导致眼眶和眼球破坏。
Optometry. 2007 Jul;78(7):344-51. doi: 10.1016/j.optm.2006.09.012.
5
Management of periocular basal and squamous cell carcinoma: a series of 485 cases.眼周基底细胞癌和鳞状细胞癌的治疗:485例病例系列
Am J Ophthalmol. 2006 Aug;142(2):293-7. doi: 10.1016/j.ajo.2006.03.055.
6
Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.土耳其人群中眼睑及眶周区域的基底细胞癌
Ophthalmic Plast Reconstr Surg. 2008 May-Jun;24(3):201-6. doi: 10.1097/IOP.0b013e31816d954d.
7
Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.眼眶周围基底细胞癌复发和眼眶浸润的预测因素
J Craniofac Surg. 2017 Jan;28(1):e84-e87. doi: 10.1097/SCS.0000000000003242.
8
The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.澳大利亚莫氏手术数据库,第二部分:眼周基底细胞癌5年随访结果。
Ophthalmology. 2004 Apr;111(4):631-6. doi: 10.1016/j.ophtha.2003.11.004.
9
Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.眼睑基底细胞癌:非莫氏手术切除、修复及结果
Br J Ophthalmol. 2005 Aug;89(8):992-4. doi: 10.1136/bjo.2004.058834.
10
Globe-sparing surgical treatment for periocular malignancies with anterior orbital invasion: a consecutive case series.球部保留手术治疗眶前部侵袭性眼周恶性肿瘤:连续病例系列。
Orbit. 2023 Oct;42(5):536-544. doi: 10.1080/01676830.2022.2141803. Epub 2023 Jan 8.

引用本文的文献

1
A Systematic Review and Meta-Analysis of Ocular and Periocular Basal Cell Carcinoma with First-Time Description of Dermoscopic and Reflectance Confocal Microscopy Features of Caruncle Basal Cell Carcinoma.眼及眼周基底细胞癌的系统评价与荟萃分析,首次描述泪阜基底细胞癌的皮肤镜及反射式共聚焦显微镜特征
Diagnostics (Basel). 2025 May 14;15(10):1244. doi: 10.3390/diagnostics15101244.
2
Advanced Periocular Basal Cell Carcinoma with Orbital Invasion: Update on Management and Treatment Advances.伴有眼眶侵犯的晚期眼周基底细胞癌:治疗与进展的最新情况
J Ophthalmol. 2024 Feb 29;2024:4347707. doi: 10.1155/2024/4347707. eCollection 2024.
3
Risk Factors for Orbital Invasion in Malignant Eyelid Tumors, Is Orbital Exenteration Still Necessary?
恶性眼睑肿瘤眼眶侵犯的危险因素,眼眶内容剜除术是否仍有必要?
J Clin Med. 2024 Jan 26;13(3):726. doi: 10.3390/jcm13030726.
4
Post-operative interventional radiotherapy (brachytherapy) in advanced ocular surface and eyelid tumors as an alternative to surgical retreatment.晚期眼表及眼睑肿瘤术后介入性放射治疗(近距离放射治疗)作为手术再治疗的替代方案
Eur J Ophthalmol. 2024 Jul;34(4):1266-1276. doi: 10.1177/11206721231215105. Epub 2023 Dec 17.
5
Mohs Surgery for Periocular Basal Cell Carcinoma Without a Mohs Surgeon: The First Series in Hong Kong.在没有莫氏外科医生的情况下对眼周基底细胞癌进行莫氏手术:香港的首个系列病例
Cureus. 2023 Mar 16;15(3):e36235. doi: 10.7759/cureus.36235. eCollection 2023 Mar.
6
Holding back the tears: is there a role for marsupialisation?忍住泪水:是否有袋育的作用?
BMJ Open Ophthalmol. 2022 Aug;7(1). doi: 10.1136/bmjophth-2022-000985.
7
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives.微小但具有挑战性的结膜黑色素瘤:新见解、范例与未来展望
Cancers (Basel). 2021 Nov 14;13(22):5691. doi: 10.3390/cancers13225691.
8
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New 'Eye-Sparing' Paradigm?局部晚期眼周恶性肿瘤的新型靶向治疗和免疫治疗:迈向新的“保眼”模式?
Cancers (Basel). 2021 Jun 5;13(11):2822. doi: 10.3390/cancers13112822.
9
Periocular basal cell carcinoma - clinical perspectives.眼周基底细胞癌——临床视角
Oncol Rev. 2020 Apr 30;14(1):420. doi: 10.4081/oncol.2020.420. eCollection 2020 Feb 18.
10
Vismodegib for periocular basal cell carcinoma: an international multicentre case series.眼周基底细胞癌的维莫德吉治疗:一项国际多中心病例系列研究。
Eye (Lond). 2020 Nov;34(11):2076-2081. doi: 10.1038/s41433-020-0778-3. Epub 2020 Jan 29.